HIV prevention has leaped forward with the development of a yearly injection that may offer long-term protection against the virus. A recent clinical trial has demonstrated promising results, suggesting that this long-acting injectable medication could serve as an effective alternative to daily oral PrEP (Pre-Exposure Prophylaxis). Scientists and medical experts believe this advancement could change the way HIV prevention is approached, especially for those who struggle with adherence to daily medication.
What is the yearly HIV injection and how does it work?
